Literature DB >> 23995175

The impact of a rehabilitation day centre program for persons suffering from schizophrenia on quality of life, social functioning and self-esteem.

Slađana Štrkalj-Ivezić1, Marijo Vrdoljak, Lana Mužinić, Mark Agius.   

Abstract

BACKGROUND: Presently few studies demonstrate improved outcomes in patients with schizophrenia treated in day rehabilitation centres. One reason is the absence of an evidence based protocol for rehabilitation in such centres. Hence further research is required to assess whether such a protocol will improve psychosocial outcomes. AIMS: We performed a controlled evaluation study of a protocol based rehabilitation day program (RDC) for persons suffering from schizophrenia.
METHODS: Patients from the experimental group (N=50) were treated within the RDC for a 6 month period. The control group were patients on the waiting list for the RDC. Quality of life (MANSA), social functioning (OSA) and self-esteem (Rosenberg) were measured before and after the intervention.
RESULTS: Statistically significant improvement was shown in social functioning measured by OSA (F(1,96)=33.7; p<0.001), quality of life measured by MANSA (F(1,96)=69.3; p<0.001) and self esteem measured by Rosenberg scale (F(1,96)=84.5; p<0.001) for patients treated in the RDC compared with the control group, conversely, the control group outcomes deteriorated.
CONCLUSION: An evidence based protocol for rehabilitation within the RDC lead to improved social outcomes and recovery for persons suffering from schizophrenia.

Entities:  

Mesh:

Year:  2013        PMID: 23995175

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  1 in total

1.  Non-pharmacological interventions for schizophrenia-analysis of treatment guidelines and implementation in 12 Southeast European countries.

Authors:  Lidija Injac Stevović; Selman Repišti; Tamara Radojičić; Norman Sartorius; Sonila Tomori; Alma Džubur Kulenović; Ana Popova; Martina Rojnić Kuzman; Ilias I Vlachos; Shukrije Statovci; Alexei Bandati; Antoni Novotni; Stojan Bajraktarov; Anca-Livia Panfil; Nadja Maric; Mirjana Delić; Nikolina Jovanović
Journal:  Schizophrenia (Heidelb)       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.